Early Thursday, Medtronic (MDT) beat fiscal fourth-quarter expectations, but MDT stock slumped on its light earnings outlook.
The medical devices company reported adjusted earnings of $1.57 per share on $8.54 billion in fiscal fourth-quarter sales. On average, analysts polled by FactSet expected Medtronic to earn $1.55 per share and report $8.26 billion in sales.
In the year-earlier period, Medtronic earned $1.52 a share on $8.09 billion in sales.
For the year, Medtronic expects 4%-4.5% organic sales growth and adjusted profit of $5-$5.10 per share. MDT stock analysts predicted $32.28 billion in sales and earnings of $5.19 a share.
Medtronic also announced it will acquire insulin patch maker EOFlow for about $738 million. EOFlow is based in South Korea and makes a tubeless, wearable and fully disposable insulin delivery device.
In premarket trading on the stock market today, MDT stock fell 3.8% near 84.20. Shares are well above their 50-day and 200-day moving averages, according to MarketSmith.com.
Still, MDT stock only has a middling IBD Digital Relative Strength Rating of 60, putting shares narrowly in the top half of all stocks when it comes to 12-month performance.
More to follow.
Follow Allison Gatlin on Twitter at @IBD_AGatlin.
YOU MAY ALSO LIKE:
Sarepta Therapeutics Dives On An Unexpected Holdup For Its Gene Therapy
IBD Stock Of The Day: Why McKesson And Its Rivals Are ‘So Hot’ Right Now
Get Timely Buy & Sell Alerts With IBD Leaderboard
Best Growth Stocks To Buy And Watch: See Updates To IBD Stock Lists